Allergy future or investigational therapies

Jump to navigation Jump to search

Allergy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Allergies from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Allergy future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Allergy future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Allergy future or investigational therapies

CDC on Allergy future or investigational therapies

Allergy future or investigational therapies in the news

Blogs on Allergy future or investigational therapies

Directions to Hospitals Treating Allergies

Risk calculators and risk factors for Allergy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Gene therapy has been shown to be a simple, efficient, and convenient treatment.

Future or Investigational Therapies

By providing the allergen or therapeutic protein in the form of plasmid DNA in vivo to modulate allergic immune responses, gene therapy has been shown to be a simple, efficient, and convenient treatment.[1]

References

  1. Chuang YH, Yang YH, Wu SJ, Chiang BL (June 2009). "Gene therapy for allergic diseases". Curr Gene Ther. 9 (3): 185–91. doi:10.2174/156652309788488604. PMID 19519363.

Template:WH Template:WS